scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1103668851 |
P356 | DOI | 10.1186/S40001-018-0318-9 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s40001-018-0318-9 |
P932 | PMC publication ID | 5921411 |
P698 | PubMed publication ID | 29703267 |
P50 | author | Peter A. Fasching | Q64005064 |
Arif B. Ekici | Q64409983 | ||
Matthias W. Beckmann | Q72940290 | ||
P2093 | author name string | C C Hack | |
H Huebner | |||
M Ruebner | |||
U G Poehls | |||
P2860 | cites work | Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2. | Q48361014 |
Volunteer's willingness to genetic testing - lack of the understanding of the matter. | Q50723512 | ||
Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model. | Q51066499 | ||
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. | Q51903876 | ||
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. | Q53464409 | ||
Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing. | Q53539898 | ||
Ten genes for inherited breast cancer. | Q53571876 | ||
Quantity and quality assessment of DNA extracted from saliva and blood. | Q54310072 | ||
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. | Q54361261 | ||
Public willingness to participate in and public opinions about genetic variation research: a review of the literature | Q56786711 | ||
Genetic testing for prostate cancer. Willingness and predictors of interest | Q56947293 | ||
Evaluation ofRAD50 in familial breast cancer predisposition | Q57266727 | ||
Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies | Q57667565 | ||
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash | Q58047464 | ||
TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis | Q58143865 | ||
Mammographic density as a risk factor for breast cancer in a German case–control study | Q62583472 | ||
BRCA2 germline mutations in male breast cancer cases and breast cancer families | Q71167609 | ||
TP53 abnormalities and genetic instability in breast cancer | Q71712670 | ||
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer | Q74299619 | ||
Breast cancer and genetic instability: the molecules behind the scenes | Q74811100 | ||
The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs | Q79222959 | ||
Stage of breast cancers found during the surveillance of women with a familial or hereditary risk | Q80446180 | ||
MRI surveillance for hereditary breast-cancer risk | Q81776012 | ||
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA | Q24569526 | ||
Quality and quantity of saliva DNA obtained from the self-administrated oragene method--a pilot study on the cohort of Swedish men | Q28264408 | ||
Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study | Q28743906 | ||
Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
Genetic variation and willingness to participate in epidemiologic research: data from three studies | Q31010279 | ||
Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinic | Q33594506 | ||
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype | Q33904762 | ||
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility | Q33904964 | ||
Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer | Q34209634 | ||
Breast cancer in European Union: an update of screening programmes as of March 2014 (review) | Q34372180 | ||
Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing | Q35570884 | ||
Possible net harms of breast cancer screening: updated modelling of Forrest report | Q35603080 | ||
Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction | Q35786337 | ||
Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutations | Q35928599 | ||
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | Q35996692 | ||
Mammographic breast density and breast cancer: evidence of a shared genetic basis | Q36043843 | ||
The contributions of breast density and common genetic variation to breast cancer risk | Q36137764 | ||
Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping | Q36397260 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation | Q36754871 | ||
Quality of DNA extracted from mouthwashes | Q37240598 | ||
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer | Q37373918 | ||
Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis | Q37660589 | ||
Hereditary breast and ovarian cancer susceptibility genes (review). | Q38115459 | ||
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study | Q38787080 | ||
Mammographic density is the main correlate of tumors detected on ultrasound but not on mammography | Q39622978 | ||
Willingness to pay for genetic testing: a study of attitudes in a Canadian population. | Q39905609 | ||
Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers. | Q40050417 | ||
Codon 72 polymorphism of the TP53 gene | Q40522948 | ||
Knowledge and willingness of breast cancer patients from Shanghai for genetic counseling and gene testing | Q40601392 | ||
Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility | Q43074406 | ||
Estimates, from salivary analyses, of the turnover time of the oral mucosal epithelium in humans and the number of bacteria in an edentulous mouth | Q44414294 | ||
Evaluation of saliva as a source of human DNA for population and association studies. | Q47211185 | ||
Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics | Q47318223 | ||
FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum | Q48090851 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 20 | |
P577 | publication date | 2018-04-27 | |
P1433 | published in | European Journal of Medical Research | Q5412732 |
P1476 | title | Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics. | |
P478 | volume | 23 |
Search more.